应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
SGMT Sagimet Biosciences Inc.
盘后交易 08-13 17:55:07 EDT
9.58
+0.03
+0.31%
盘后
9.58
+0.00
0.00%
17:37 EDT
最高
10.06
最低
9.45
成交量
65.87万
今开
9.63
昨收
9.55
日振幅
6.41%
总市值
3.08亿
流通市值
2.21亿
总股本
3,220万
成交额
642.12万
换手率
2.85%
流通股本
2,310万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Sagimet Biosciences Inc. - Series A盘中异动 急速拉升5.38%
市场透视 · 08-11 15:55
Sagimet Biosciences Inc. - Series A盘中异动 急速拉升5.38%
Sagimet Biosciences Inc. - Series A盘中异动 临近收盘大幅拉升5.33%
市场透视 · 08-04
Sagimet Biosciences Inc. - Series A盘中异动 临近收盘大幅拉升5.33%
Sagimet Biosciences Inc. - Series A盘中异动 早盘急速跳水5.06%报8.25美元
市场透视 · 08-01
Sagimet Biosciences Inc. - Series A盘中异动 早盘急速跳水5.06%报8.25美元
Sagimet Biosciences Inc. - Series A盘中异动 下午盘急速下跌5.07%
市场透视 · 07-30
Sagimet Biosciences Inc. - Series A盘中异动 下午盘急速下跌5.07%
Sagimet Biosciences Inc. - Series A盘中异动 早盘股价大跌5.13%报9.71美元
市场透视 · 07-29
Sagimet Biosciences Inc. - Series A盘中异动 早盘股价大跌5.13%报9.71美元
Sagimet Biosciences Inc. - Series A盘中异动 早盘快速下跌5.57%报9.67美元
市场透视 · 07-28
Sagimet Biosciences Inc. - Series A盘中异动 早盘快速下跌5.57%报9.67美元
Sagimet Biosciences Inc. - Series A盘中异动 临近午盘股价大涨5.05%报9.98美元
市场透视 · 07-10
Sagimet Biosciences Inc. - Series A盘中异动 临近午盘股价大涨5.05%报9.98美元
Sagimet Biosciences Inc. - Series A盘中异动 早盘股价大涨5.57%
市场透视 · 07-09
Sagimet Biosciences Inc. - Series A盘中异动 早盘股价大涨5.57%
Sagimet Biosciences Inc. - Series A盘中异动 下午盘快速上涨5.21%报8.68美元
市场透视 · 07-07
Sagimet Biosciences Inc. - Series A盘中异动 下午盘快速上涨5.21%报8.68美元
Sagimet Biosciences Inc. - Series A盘中异动 快速上涨5.12%
市场透视 · 07-01
Sagimet Biosciences Inc. - Series A盘中异动 快速上涨5.12%
Sagimet Biosciences Inc. - Series A盘中异动 早盘股价大跌5.26%报8.24美元
市场透视 · 06-27
Sagimet Biosciences Inc. - Series A盘中异动 早盘股价大跌5.26%报8.24美元
Sagimet Biosciences Inc. - Series A盘中异动 股价大跌5.09%
市场透视 · 06-25
Sagimet Biosciences Inc. - Series A盘中异动 股价大跌5.09%
Sagimet Biosciences Inc. - Series A盘中异动 早盘大幅下挫5.01%
市场透视 · 06-23
Sagimet Biosciences Inc. - Series A盘中异动 早盘大幅下挫5.01%
Sagimet Biosciences Inc. - Series A盘中异动 大幅拉升5.11%
市场透视 · 06-20
Sagimet Biosciences Inc. - Series A盘中异动 大幅拉升5.11%
Sagimet Biosciences Inc. - Series A盘中异动 早盘股价大跌5.13%
市场透视 · 06-17
Sagimet Biosciences Inc. - Series A盘中异动 早盘股价大跌5.13%
Sagimet Biosciences Inc. - Series A盘中异动 早盘急速上涨6.05%报8.77美元
市场透视 · 06-16
Sagimet Biosciences Inc. - Series A盘中异动 早盘急速上涨6.05%报8.77美元
Sagimet Biosciences Inc. - Series A盘中异动 股价大涨5.23%
市场透视 · 06-13
Sagimet Biosciences Inc. - Series A盘中异动 股价大涨5.23%
Sagimet Biosciences Inc. - Series A盘中异动 早盘大幅拉升5.49%报6.53美元
市场透视 · 06-12
Sagimet Biosciences Inc. - Series A盘中异动 早盘大幅拉升5.49%报6.53美元
Sagimet Biosciences Inc. - Series A盘中异动 早盘股价大涨5.44%
市场透视 · 06-10
Sagimet Biosciences Inc. - Series A盘中异动 早盘股价大涨5.44%
Sagimet Biosciences Inc. - Series A盘中异动 快速跳水6.44%
市场透视 · 06-09
Sagimet Biosciences Inc. - Series A盘中异动 快速跳水6.44%
加载更多
公司概况
公司名称:
Sagimet Biosciences Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Sagimet Biosciences Inc.于2006年12月19日在特拉华州注册成立,名称为3-V Biosciences,Inc.,总部位于加利福尼亚州圣马特奥。该公司于2019年8月将其名称从3-V Biosciences,Inc.更改为Sagimet Biosciences Inc.。该公司是临床阶段的生物制药公司,致力于开发内部发现的选择性脂肪酸合酶抑制剂组合,用于治疗因脂质代谢功能障碍而导致的疾病。
发行价格:
--
{"stockData":{"symbol":"SGMT","market":"US","secType":"STK","nameCN":"Sagimet Biosciences Inc.","latestPrice":9.58,"timestamp":1755115200000,"preClose":9.55,"halted":0,"volume":658696,"hourTrading":{"tag":"盘后","latestPrice":9.58,"preClose":9.58,"latestTime":"17:37 EDT","volume":1496,"amount":14339.6088,"timestamp":1755121061139},"delay":0,"floatShares":23097623,"shares":32195345,"eps":-1.777054,"marketStatus":"盘后交易","change":0.03,"latestTime":"08-13 17:55:07 EDT","open":9.63,"high":10.0624,"low":9.45,"amount":6421162.264624,"amplitude":0.064126,"askPrice":9.75,"askSize":50,"bidPrice":9.2,"bidSize":40,"shortable":3,"etf":0,"ttmEps":-1.777054,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1755129600000},"marketStatusCode":4,"adr":0,"listingDate":1689307200000,"exchange":"NASDAQ","adjPreClose":9.55,"preHourTrading":{"tag":"盘前","latestPrice":9.47,"preClose":9.55,"latestTime":"09:00 EDT","volume":3155,"amount":30332.248875,"timestamp":1755090028186},"postHourTrading":{"tag":"盘后","latestPrice":9.58,"preClose":9.58,"latestTime":"17:37 EDT","volume":1496,"amount":14339.6088,"timestamp":1755121061139},"volumeRatio":1.41339,"impliedVol":1.1109,"impliedVolPercentile":0.06},"requestUrl":"/m/hq/s/SGMT","defaultTab":"news","newsList":[{"id":"2558866487","title":"Sagimet Biosciences Inc. - Series A盘中异动 急速拉升5.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2558866487","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558866487?lang=zh_cn&edition=full","pubTime":"2025-08-11 23:55","pubTimestamp":1754927754,"startTime":"0","endTime":"0","summary":"北京时间2025年08月11日23时55分,Sagimet Biosciences Inc. - Series A股票出现异动,股价快速上涨5.38%。Sagimet Biosciences Inc. - Series A股票所在的生物技术行业中,整体涨幅为0.26%。Sagimet Biosciences Inc. - Series A公司简介:Sagimet Biosciences Inc 是一家临床阶段的生物制药公司,致力于开发一系列内部发现的选择性脂肪酸合成酶抑制剂,旨在治疗由脂质代谢途径失调引起的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025081123555494dcf5d9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025081123555494dcf5d9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SGMT","BK4139"],"gpt_icon":0},{"id":"2557393033","title":"Sagimet Biosciences Inc. - Series A盘中异动 临近收盘大幅拉升5.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557393033","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557393033?lang=zh_cn&edition=full","pubTime":"2025-08-05 03:43","pubTimestamp":1754336586,"startTime":"0","endTime":"0","summary":"北京时间2025年08月05日03时43分,Sagimet Biosciences Inc. - Series A股票出现波动,股价急速拉升5.33%。Sagimet Biosciences Inc. - Series A股票所在的生物技术行业中,整体涨幅为1.61%。Sagimet Biosciences Inc. - Series A公司简介:Sagimet Biosciences Inc 是一家临床阶段的生物制药公司,致力于开发一系列内部发现的选择性脂肪酸合成酶抑制剂,旨在治疗由脂质代谢途径失调引起的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080503430694cf85c6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080503430694cf85c6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SGMT"],"gpt_icon":0},{"id":"2556817829","title":"Sagimet Biosciences Inc. - Series A盘中异动 早盘急速跳水5.06%报8.25美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2556817829","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556817829?lang=zh_cn&edition=full","pubTime":"2025-08-01 23:01","pubTimestamp":1754060505,"startTime":"0","endTime":"0","summary":"北京时间2025年08月01日23时01分,Sagimet Biosciences Inc. - Series A股票出现异动,股价急速下跌5.06%。Sagimet Biosciences Inc. - Series A股票所在的生物技术行业中,整体跌幅为0.11%。Sagimet Biosciences Inc. - Series A公司简介:Sagimet Biosciences Inc 是一家临床阶段的生物制药公司,致力于开发一系列内部发现的选择性脂肪酸合成酶抑制剂,旨在治疗由脂质代谢途径失调引起的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801230146a470035b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801230146a470035b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SGMT","BK4139"],"gpt_icon":0},{"id":"2555902961","title":"Sagimet Biosciences Inc. - Series A盘中异动 下午盘急速下跌5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2555902961","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555902961?lang=zh_cn&edition=full","pubTime":"2025-07-31 02:57","pubTimestamp":1753901841,"startTime":"0","endTime":"0","summary":"北京时间2025年07月31日02时57分,Sagimet Biosciences Inc. - Series A股票出现异动,股价快速下挫5.07%。Sagimet Biosciences Inc. - Series A股票所在的生物技术行业中,整体涨幅为0.35%。Sagimet Biosciences Inc. - Series A公司简介:Sagimet Biosciences Inc 是一家临床阶段的生物制药公司,致力于开发一系列内部发现的选择性脂肪酸合成酶抑制剂,旨在治疗由脂质代谢途径失调引起的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025073102572297285ed3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025073102572297285ed3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SGMT","BK4139"],"gpt_icon":0},{"id":"2555050244","title":"Sagimet Biosciences Inc. - Series A盘中异动 早盘股价大跌5.13%报9.71美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555050244","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555050244?lang=zh_cn&edition=full","pubTime":"2025-07-29 22:52","pubTimestamp":1753800726,"startTime":"0","endTime":"0","summary":"北京时间2025年07月29日22时52分,Sagimet Biosciences Inc. - Series A股票出现异动,股价急速跳水5.13%。Sagimet Biosciences Inc. - Series A股票所在的生物技术行业中,整体涨幅为0.42%。Sagimet Biosciences Inc. - Series A公司简介:Sagimet Biosciences Inc 是一家临床阶段的生物制药公司,致力于开发一系列内部发现的选择性脂肪酸合成酶抑制剂,旨在治疗由脂质代谢途径失调引起的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729225206a469e393&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729225206a469e393&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SGMT","BK4139"],"gpt_icon":0},{"id":"2554777721","title":"Sagimet Biosciences Inc. - Series A盘中异动 早盘快速下跌5.57%报9.67美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2554777721","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554777721?lang=zh_cn&edition=full","pubTime":"2025-07-28 22:19","pubTimestamp":1753712367,"startTime":"0","endTime":"0","summary":"北京时间2025年07月28日22时19分,Sagimet Biosciences Inc. - Series A股票出现波动,股价快速跳水5.57%。Sagimet Biosciences Inc. - Series A股票所在的生物技术行业中,整体涨幅为0.20%。Sagimet Biosciences Inc. - Series A公司简介:Sagimet Biosciences Inc 是一家临床阶段的生物制药公司,致力于开发一系列内部发现的选择性脂肪酸合成酶抑制剂,旨在治疗由脂质代谢途径失调引起的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250728221927a6c625e5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250728221927a6c625e5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SGMT"],"gpt_icon":0},{"id":"2550622535","title":"Sagimet Biosciences Inc. - Series A盘中异动 临近午盘股价大涨5.05%报9.98美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550622535","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550622535?lang=zh_cn&edition=full","pubTime":"2025-07-10 23:35","pubTimestamp":1752161719,"startTime":"0","endTime":"0","summary":"北京时间2025年07月10日23时35分,Sagimet Biosciences Inc. - Series A股票出现异动,股价快速上涨5.05%。Sagimet Biosciences Inc. - Series A股票所在的生物技术行业中,整体涨幅为0.70%。Sagimet Biosciences Inc. - Series A公司简介:Sagimet Biosciences Inc 是一家临床阶段的生物制药公司,致力于开发一系列内部发现的选择性脂肪酸合成酶抑制剂,旨在治疗由脂质代谢途径失调引起的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710233520953d9da7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710233520953d9da7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SGMT","BK4139"],"gpt_icon":0},{"id":"2550565176","title":"Sagimet Biosciences Inc. - Series A盘中异动 早盘股价大涨5.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2550565176","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550565176?lang=zh_cn&edition=full","pubTime":"2025-07-09 22:05","pubTimestamp":1752069926,"startTime":"0","endTime":"0","summary":"北京时间2025年07月09日22时05分,Sagimet Biosciences Inc. - Series A股票出现波动,股价急速上涨5.57%。Sagimet Biosciences Inc. - Series A股票所在的生物技术行业中,整体涨幅为1.28%。Sagimet Biosciences Inc. - Series A公司简介:Sagimet Biosciences Inc 是一家临床阶段的生物制药公司,致力于开发一系列内部发现的选择性脂肪酸合成酶抑制剂,旨在治疗由脂质代谢途径失调引起的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709220526a69f9a2c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709220526a69f9a2c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SGMT","BK4139"],"gpt_icon":0},{"id":"2549577045","title":"Sagimet Biosciences Inc. - Series A盘中异动 下午盘快速上涨5.21%报8.68美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2549577045","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549577045?lang=zh_cn&edition=full","pubTime":"2025-07-08 03:12","pubTimestamp":1751915540,"startTime":"0","endTime":"0","summary":"北京时间2025年07月08日03时12分,Sagimet Biosciences Inc. - Series A股票出现波动,股价大幅拉升5.21%。Sagimet Biosciences Inc. - Series A股票所在的生物技术行业中,整体跌幅为0.70%。Sagimet Biosciences Inc. - Series A公司简介:Sagimet Biosciences Inc 是一家临床阶段的生物制药公司,致力于开发一系列内部发现的选择性脂肪酸合成酶抑制剂,旨在治疗由脂质代谢途径失调引起的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507080312209539e125&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507080312209539e125&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SGMT","BK4139"],"gpt_icon":0},{"id":"2548885180","title":"Sagimet Biosciences Inc. - Series A盘中异动 快速上涨5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2548885180","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548885180?lang=zh_cn&edition=full","pubTime":"2025-07-01 23:56","pubTimestamp":1751385390,"startTime":"0","endTime":"0","summary":"北京时间2025年07月01日23时56分,Sagimet Biosciences Inc. - Series A股票出现波动,股价急速拉升5.12%。Sagimet Biosciences Inc. - Series A股票所在的生物技术行业中,整体涨幅为1.24%。Sagimet Biosciences Inc. - Series A公司简介:Sagimet Biosciences Inc 是一家临床阶段的生物制药公司,致力于开发一系列内部发现的选择性脂肪酸合成酶抑制剂,旨在治疗由脂质代谢途径失调引起的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025070123563097961762&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025070123563097961762&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SGMT","BK4139"],"gpt_icon":0},{"id":"2546744390","title":"Sagimet Biosciences Inc. - Series A盘中异动 早盘股价大跌5.26%报8.24美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546744390","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546744390?lang=zh_cn&edition=full","pubTime":"2025-06-27 21:59","pubTimestamp":1751032747,"startTime":"0","endTime":"0","summary":"北京时间2025年06月27日21时59分,Sagimet Biosciences Inc. - Series A股票出现异动,股价急速跳水5.26%。Sagimet Biosciences Inc. - Series A股票所在的生物技术行业中,整体涨幅为0.19%。Sagimet Biosciences Inc. - Series A公司简介:Sagimet Biosciences Inc 是一家临床阶段的生物制药公司,致力于开发一系列内部发现的选择性脂肪酸合成酶抑制剂,旨在治疗由脂质代谢途径失调引起的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250627215907952e3248&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250627215907952e3248&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SGMT"],"gpt_icon":0},{"id":"2546246484","title":"Sagimet Biosciences Inc. - Series A盘中异动 股价大跌5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2546246484","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546246484?lang=zh_cn&edition=full","pubTime":"2025-06-25 22:06","pubTimestamp":1750860360,"startTime":"0","endTime":"0","summary":"北京时间2025年06月25日22时06分,Sagimet Biosciences Inc. - Series A股票出现波动,股价快速跳水5.09%。Sagimet Biosciences Inc. - Series A股票所在的生物技术行业中,整体跌幅为0.86%。Sagimet Biosciences Inc. - Series A公司简介:Sagimet Biosciences Inc 是一家临床阶段的生物制药公司,致力于开发一系列内部发现的选择性脂肪酸合成酶抑制剂,旨在治疗由脂质代谢途径失调引起的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625220600952b4536&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625220600952b4536&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SGMT"],"gpt_icon":0},{"id":"2545443121","title":"Sagimet Biosciences Inc. - Series A盘中异动 早盘大幅下挫5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2545443121","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545443121?lang=zh_cn&edition=full","pubTime":"2025-06-23 22:57","pubTimestamp":1750690653,"startTime":"0","endTime":"0","summary":"北京时间2025年06月23日22时57分,Sagimet Biosciences Inc. - Series A股票出现波动,股价大幅下挫5.01%。Sagimet Biosciences Inc. - Series A股票所在的生物技术行业中,整体涨幅为0.23%。Sagimet Biosciences Inc. - Series A公司简介:Sagimet Biosciences Inc 是一家临床阶段的生物制药公司,致力于开发一系列内部发现的选择性脂肪酸合成酶抑制剂,旨在治疗由脂质代谢途径失调引起的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025062322573395282c64&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025062322573395282c64&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SGMT","BK4139"],"gpt_icon":0},{"id":"2544200391","title":"Sagimet Biosciences Inc. - Series A盘中异动 大幅拉升5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2544200391","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544200391?lang=zh_cn&edition=full","pubTime":"2025-06-20 21:31","pubTimestamp":1750426291,"startTime":"0","endTime":"0","summary":"北京时间2025年06月20日21时31分,Sagimet Biosciences Inc. - Series A股票出现波动,股价急速上涨5.11%。Sagimet Biosciences Inc. - Series A股票所在的生物技术行业中,整体涨幅为0.39%。Sagimet Biosciences Inc. - Series A公司简介:Sagimet Biosciences Inc 是一家临床阶段的生物制药公司,致力于开发一系列内部发现的选择性脂肪酸合成酶抑制剂,旨在治疗由脂质代谢途径失调引起的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250620213131978808a3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250620213131978808a3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SGMT"],"gpt_icon":0},{"id":"2544996022","title":"Sagimet Biosciences Inc. - Series A盘中异动 早盘股价大跌5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2544996022","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544996022?lang=zh_cn&edition=full","pubTime":"2025-06-17 23:16","pubTimestamp":1750173378,"startTime":"0","endTime":"0","summary":"北京时间2025年06月17日23时16分,Sagimet Biosciences Inc. - Series A股票出现波动,股价大幅跳水5.13%。Sagimet Biosciences Inc. - Series A股票所在的生物技术行业中,整体跌幅为0.69%。Sagimet Biosciences Inc. - Series A公司简介:Sagimet Biosciences Inc 是一家临床阶段的生物制药公司,致力于开发一系列内部发现的选择性脂肪酸合成酶抑制剂,旨在治疗由脂质代谢途径失调引起的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250617231618a4ae9d50&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250617231618a4ae9d50&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SGMT","BK4139"],"gpt_icon":0},{"id":"2543608555","title":"Sagimet Biosciences Inc. - Series A盘中异动 早盘急速上涨6.05%报8.77美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2543608555","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543608555?lang=zh_cn&edition=full","pubTime":"2025-06-16 21:31","pubTimestamp":1750080685,"startTime":"0","endTime":"0","summary":"北京时间2025年06月16日21时31分,Sagimet Biosciences Inc. - Series A股票出现异动,股价快速上涨6.05%。Sagimet Biosciences Inc. - Series A股票所在的生物技术行业中,整体涨幅为0.02%。Sagimet Biosciences Inc. - Series A公司简介:Sagimet Biosciences Inc 是一家临床阶段的生物制药公司,致力于开发一系列内部发现的选择性脂肪酸合成酶抑制剂,旨在治疗由脂质代谢途径失调引起的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506162131259781ec3d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506162131259781ec3d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SGMT","BK4139"],"gpt_icon":0},{"id":"2543636125","title":"Sagimet Biosciences Inc. - Series A盘中异动 股价大涨5.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2543636125","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543636125?lang=zh_cn&edition=full","pubTime":"2025-06-14 00:00","pubTimestamp":1749830424,"startTime":"0","endTime":"0","summary":"北京时间2025年06月14日00时00分,Sagimet Biosciences Inc. - Series A股票出现异动,股价急速上涨5.23%。Sagimet Biosciences Inc. - Series A股票所在的生物技术行业中,整体跌幅为0.30%。Sagimet Biosciences Inc. - Series A公司简介:Sagimet Biosciences Inc 是一家临床阶段的生物制药公司,致力于开发一系列内部发现的选择性脂肪酸合成酶抑制剂,旨在治疗由脂质代谢途径失调引起的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250614000025a707da80&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250614000025a707da80&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SGMT","BK4139"],"gpt_icon":0},{"id":"2542510552","title":"Sagimet Biosciences Inc. - Series A盘中异动 早盘大幅拉升5.49%报6.53美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2542510552","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542510552?lang=zh_cn&edition=full","pubTime":"2025-06-12 21:51","pubTimestamp":1749736308,"startTime":"0","endTime":"0","summary":"北京时间2025年06月12日21时51分,Sagimet Biosciences Inc. - Series A股票出现异动,股价急速拉升5.49%。Sagimet Biosciences Inc. - Series A股票所在的生物技术行业中,整体涨幅为0.25%。Sagimet Biosciences Inc. - Series A公司简介:Sagimet Biosciences Inc 是一家临床阶段的生物制药公司,致力于开发一系列内部发现的选择性脂肪酸合成酶抑制剂,旨在治疗由脂质代谢途径失调引起的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250612215148951990da&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250612215148951990da&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SGMT","BK4139"],"gpt_icon":0},{"id":"2542364345","title":"Sagimet Biosciences Inc. - Series A盘中异动 早盘股价大涨5.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2542364345","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542364345?lang=zh_cn&edition=full","pubTime":"2025-06-10 22:54","pubTimestamp":1749567295,"startTime":"0","endTime":"0","summary":"北京时间2025年06月10日22时54分,Sagimet Biosciences Inc. - Series A股票出现波动,股价大幅拉升5.44%。Sagimet Biosciences Inc. - Series A股票所在的生物技术行业中,整体涨幅为0.79%。消息层面,截至22时54分,《Jones Trading:维持Sagimet Biosciences评级,由买入调整至买入评级, 目标价由15.00美元调整至27.00美元。》资讯为影响Sagimet Biosciences Inc. - Series A的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250610225455a4a21c72&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250610225455a4a21c72&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SGMT"],"gpt_icon":0},{"id":"2542387027","title":"Sagimet Biosciences Inc. - Series A盘中异动 快速跳水6.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2542387027","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542387027?lang=zh_cn&edition=full","pubTime":"2025-06-09 21:33","pubTimestamp":1749476029,"startTime":"0","endTime":"0","summary":"北京时间2025年06月09日21时33分,Sagimet Biosciences Inc. - Series A股票出现异动,股价大幅跳水6.44%。Sagimet Biosciences Inc. - Series A股票所在的生物技术行业中,整体涨幅为0.62%。消息层面,截至21时33分,《Jones Trading:维持Sagimet Biosciences评级,由买入调整至买入评级, 目标价由15.00美元调整至27.00美元。》资讯为影响Sagimet Biosciences Inc. - Series A的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506092133499777e747&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506092133499777e747&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SGMT","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.sagimet.com","stockEarnings":[{"period":"1week","weight":0.0658},{"period":"1month","weight":0.0084},{"period":"3month","weight":2.0806},{"period":"6month","weight":1.1705},{"period":"1year","weight":2.6106},{"period":"ytd","weight":1.1222}],"compareEarnings":[{"period":"1week","weight":0.0234},{"period":"1month","weight":0.0306},{"period":"3month","weight":0.0938},{"period":"6month","weight":0.0541},{"period":"1year","weight":0.2052},{"period":"ytd","weight":0.0966}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Sagimet Biosciences Inc.于2006年12月19日在特拉华州注册成立,名称为3-V Biosciences,Inc.,总部位于加利福尼亚州圣马特奥。该公司于2019年8月将其名称从3-V Biosciences,Inc.更改为Sagimet Biosciences Inc.。该公司是临床阶段的生物制药公司,致力于开发内部发现的选择性脂肪酸合酶抑制剂组合,用于治疗因脂质代谢功能障碍而导致的疾病。","exchange":"NASDAQ","name":"Sagimet Biosciences Inc.","nameEN":"Sagimet Biosciences Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.7","shortVersion":"4.34.7","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Sagimet Biosciences Inc.(SGMT)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Sagimet Biosciences Inc.(SGMT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Sagimet Biosciences Inc.,SGMT,Sagimet Biosciences Inc.股票,Sagimet Biosciences Inc.股票老虎,Sagimet Biosciences Inc.股票老虎国际,Sagimet Biosciences Inc.行情,Sagimet Biosciences Inc.股票行情,Sagimet Biosciences Inc.股价,Sagimet Biosciences Inc.股市,Sagimet Biosciences Inc.股票价格,Sagimet Biosciences Inc.股票交易,Sagimet Biosciences Inc.股票购买,Sagimet Biosciences Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Sagimet Biosciences Inc.(SGMT)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Sagimet Biosciences Inc.(SGMT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}